Archive
All News
Every briefing, headline, and filing we've published, newest first.
The WeekPharmaceutical Technology ↗
Bayer's Kerendia will become available to English patients with chronic heart failure with preserved or mildly…
The WeekFiercePharma ↗
Foundation Medicine has started the "Quality First" initiative to create awareness of how "not all cancer biom…
The WeekFierceBiotech ↗
GSK has ended development of camlipixant in chronic cough after delivering mixed phase 3 data, dealing a major…
The WeekDrug Channels ↗
Today's guest post comes from Divya Iyer, SVP, Head of Revenue, Pharma Direct at GoodRx. Divya examines why di…
The WeekDrug Channels ↗
Today's guest post comes from Divya Iyer, SVP, Head of Revenue, Pharma Direct at GoodRx. Divya examines why di…
The WeekPharmaceutical Technology ↗
MSD has outpaced rivals to market the first PCSK9 inhibitor in pill form for patients with high cholesterol.…
The WeekSTAT News ↗
Advocates worry that excluding trans youth in some way from LGBTQ+ counseling services provided through the 98…
The WeekBioPharma Dive ↗
The latest in a prolific streak of buyouts by Lilly is the strongest sign yet that large pharmaceutical compan…
The WeekPharmaVoice ↗
Deep Origin is attempting to create "virtual humans" that could one day reduce late-stage safety failures and …
The WeekFiercePharma ↗
Merck & Co.'s almighty Keytruda has become the first PD-1 inhibitor to show a benefit as a single agent fo…
The WeekFierceBiotech ↗
Vogenx has joined the growing queue for the Nasdaq, as the metabolic biotech eyes an IPO to fund its SGLT1 inh…
The WeekBriefing
Biogen reported mid-stage trial data showing its Alzheimer’s drug slowed cognitive decline at rates similar to…
The WeekSTAT News ↗
Amylyx Pharmaceuticals will soon read out results from a study evaluating a new treatment for a rare endocrine…
The WeekBioPharma Dive ↗
Still, shares fell by nearly 20% after the company revealed a delay in the coming launch of Revtorpyk. Details…
The WeekPharmaVoice ↗
Some of the industry's most closely-watched AI drugs could provide insight into the success of technology-assi…
The WeekFiercePharma ↗
The FDA has approved a new small molecule inhibitor from Celcuity with blockbuster potential that could become…
The WeekFierceBiotech ↗
Attovia Therapeutics has filed for an IPO to secure funding for assets including a potential challenger to San…
The WeekBriefing
FDA authorizes first generic afatinib tablets for metastatic NSCLC, signaling the end of exclusivity for GILOT…
The WeekBriefing
Drug Channels highlights that while Medicare implemented site-neutral payments over a decade ago, most employe…
The WeekDrug Channels ↗
By Adam J. Fein, Ph.D.The 340B Drug Pricing Program continues to redefine the meaning of "skyrocketing." For 2…
The WeekDrug Channels ↗
By Adam J. Fein, Ph.D.The 340B Drug Pricing Program continues to redefine the meaning of "skyrocketing." For 2…
The WeekSTAT News ↗
Blumenthal, Hawley press UnitedHealth, Humana, CVS for documents related to using AI to deny or delay care.…
The WeekBioPharma Dive ↗
Terms of the deal announced Tuesday are very similar to those the FTC reached with Express Scripts earlier thi…
The WeekPharmaVoice ↗
The right target but the wrong approach? Why Galimedix's CEO believes the company has found an edge in treatin…
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.